{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:03:48Z","timestamp":1780308228063,"version":"3.54.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,6,3]]},"DOI":"10.1080\/17474086.2026.2649831","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:13:50Z","timestamp":1774008830000},"page":"641-651","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety profile of busulfan plus low-dose melphalan (BUMEL) versus high-dose melphalan (MEL200) as a conditioning regimen for autologous hematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma patients: a systematic review and meta-analysis"],"prefix":"10.1080","volume":"19","author":[{"given":"Shahzaib","family":"Maqbool","sequence":"first","affiliation":[{"name":"Department of Internal Medicine","place":["Independence, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Khan","sequence":"additional","affiliation":[{"name":"NYC H+H\/Woodhull","place":["Brooklyn, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Rawalpindi Medical University","place":["Rawalpindi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aye Mon","family":"Thida","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplant","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamamd Salman","family":"Faisal","sequence":"additional","affiliation":[{"name":"Oklahoma University Health Sciences Center","place":["Oklahoma City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Faraz","sequence":"additional","affiliation":[{"name":"Rawalpindi Medical University","place":["Rawalpindi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abat","family":"Khan","sequence":"additional","affiliation":[{"name":"Memorial Cancer Institute","place":["Hollywood, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moazzam","family":"Shahzad","sequence":"additional","affiliation":[{"name":"University of South Florida","place":["Tampa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ebad Ur","family":"Rehman","sequence":"additional","affiliation":[{"name":"Rawalpindi Medical University","place":["Rawalpindi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qurat Ul Ain","family":"Muhammad","sequence":"additional","affiliation":[{"name":"Rawalpindi Medical University","place":["Rawalpindi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur","family":"Rehman","sequence":"additional","affiliation":[{"name":"Rawalpindi Medical University","place":["Rawalpindi, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2016.11.004"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116129"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0002"},{"issue":"2","key":"e_1_3_7_6_1","first-page":"163","article-title":"High-dose therapy with autologous stem-cell transplantation for multiple myeloma in the era of novel agents: a systematic review and meta-analysis","volume":"17","author":"Koreth J","year":"2011","unstructured":"Koreth J, Cutler CS, Djulbegovic B, et al. High-dose therapy with autologous stem-cell transplantation for multiple myeloma in the era of novel agents: a systematic review and meta-analysis. Biol Blood Marrow Transpl. 2011;17(2):163\u2013173.","journal-title":"Biol Blood Marrow Transpl"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714678"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701763"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.3.731"},{"issue":"5","key":"e_1_3_7_10_1","first-page":"1113","article-title":"Role of busulfan-based conditioning regimens in multiple myeloma autotransplantation","volume":"62","author":"Branca A","year":"2021","unstructured":"Branca A, Cerchione C, Martinelli G, et al. Role of busulfan-based conditioning regimens in multiple myeloma autotransplantation. Leuk Lymphoma. 2021;62(5):1113\u20131121.","journal-title":"Leuk Lymphoma"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30114-4"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02313-z"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.13105\/wjma.v5.i4.80"},{"issue":"4","key":"e_1_3_7_15_1","first-page":"e1","article-title":"High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 gem trial","volume":"136","author":"Lahuerta JJ","year":"2025","unstructured":"Lahuerta JJ, San-Miguel J, Jim\u00e9nez-Ubieto A, et al. High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 gem trial. Blood. 2025;136(4):e1\u2013e11.","journal-title":"Blood"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30023-7"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03663-5"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.5045\/br.2018.53.2.105"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1811275"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05308-0"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190210194"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.028027"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.03.016"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200369"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1783448"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002590"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0414"},{"issue":"10","key":"e_1_3_7_28_1","first-page":"S260","article-title":"Personalized busulfan dosing improves outcomes in hematopoietic cell transplantation","volume":"22","author":"Pasquini MC","year":"2016","unstructured":"Pasquini MC, Zhu X, Coombs CC, et al. Personalized busulfan dosing improves outcomes in hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2016;22(10):S260\u20131.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"e_1_3_7_29_1","first-page":"579","article-title":"Busulfan\u2013cyclophosphamide versus melphalan 200 mg\/m2 after proteasome inhibitor and IMiD-based induction in multiple myeloma: a multicenter retrospective analysis","volume":"59","author":"Jeon YW","year":"2024","unstructured":"Jeon YW, Park CJ, Kim S, et al. Busulfan\u2013cyclophosphamide versus melphalan 200 mg\/m2 after proteasome inhibitor and IMiD-based induction in multiple myeloma: a multicenter retrospective analysis. Bone Marrow Transpl. 2024;59(4):579\u2013587.","journal-title":"Bone Marrow Transpl"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.94"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101162"},{"issue":"3","key":"e_1_3_7_32_1","first-page":"364","article-title":"Busulfan and cyclophosphamide conditioning in autologous stem cell transplantation for multiple myeloma","volume":"33","author":"Talamo G","year":"2009","unstructured":"Talamo G, Barlogie B, Tricot G, et al. Busulfan and cyclophosphamide conditioning in autologous stem cell transplantation for multiple myeloma. Leuk Res. 2009;33(3):364\u2013367.","journal-title":"Leuk Res"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014635"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.03.021"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.01.036"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.01.004"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0384"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.922182"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2789"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.05.020"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02413-0"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2649831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:26:13Z","timestamp":1780305973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2026.2649831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,3]]}},"alternative-id":["10.1080\/17474086.2026.2649831"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2026.2649831","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}